
Gollamudi S. Kishore
Examiner (ID: 18204, Phone: (571)272-0598 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1502, 1503, 1612, 2899, 1615 |
| Total Applications | 3055 |
| Issued Applications | 1377 |
| Pending Applications | 265 |
| Abandoned Applications | 1411 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15960669
[patent_doc_number] => 20200164086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => FUSOGENIC LIPOSOMES, COMPOSITIONS, KITS AND USE THEREOF FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/657347
[patent_app_country] => US
[patent_app_date] => 2019-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16657347
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/657347 | FUSOGENIC LIPOSOMES, COMPOSITIONS, KITS AND USE THEREOF FOR TREATING CANCER | Oct 17, 2019 | Abandoned |
Array
(
[id] => 16310643
[patent_doc_number] => 20200289381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => DMS (derma membrane structure) in Foam Creams
[patent_app_type] => utility
[patent_app_number] => 16/601733
[patent_app_country] => US
[patent_app_date] => 2019-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16601733
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/601733 | DMS (derma membrane structure) in Foam Creams | Oct 14, 2019 | Abandoned |
Array
(
[id] => 16153495
[patent_doc_number] => 20200214980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/592263
[patent_app_country] => US
[patent_app_date] => 2019-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16592263
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/592263 | NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS | Oct 2, 2019 | Abandoned |
Array
(
[id] => 16153495
[patent_doc_number] => 20200214980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/592263
[patent_app_country] => US
[patent_app_date] => 2019-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16592263
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/592263 | NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS | Oct 2, 2019 | Abandoned |
Array
(
[id] => 16251989
[patent_doc_number] => 20200261363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL
[patent_app_type] => utility
[patent_app_number] => 16/585347
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16585347
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/585347 | LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL | Sep 26, 2019 | Abandoned |
Array
(
[id] => 17798980
[patent_doc_number] => 11413244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Liposome composition and pharmaceutical composition
[patent_app_type] => utility
[patent_app_number] => 16/583518
[patent_app_country] => US
[patent_app_date] => 2019-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 15476
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16583518
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/583518 | Liposome composition and pharmaceutical composition | Sep 25, 2019 | Issued |
Array
(
[id] => 18050713
[patent_doc_number] => 11524080
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-13
[patent_title] => Methods for the preparation of a pharmaceutical-vesicle formulation and associated products and uses
[patent_app_type] => utility
[patent_app_number] => 17/273059
[patent_app_country] => US
[patent_app_date] => 2019-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 14614
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273059
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/273059 | Methods for the preparation of a pharmaceutical-vesicle formulation and associated products and uses | Sep 12, 2019 | Issued |
Array
(
[id] => 16259875
[patent_doc_number] => 10751283
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-25
[patent_title] => Liposomal rehydration salt formulation and associated methods of use
[patent_app_type] => utility
[patent_app_number] => 16/554797
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13380
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16554797
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/554797 | Liposomal rehydration salt formulation and associated methods of use | Aug 28, 2019 | Issued |
Array
(
[id] => 19225512
[patent_doc_number] => 12005142
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Sustained-release compositions comprising a therapeutic agent for treating depression or anxiety and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/264552
[patent_app_country] => US
[patent_app_date] => 2019-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5672
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264552
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264552 | Sustained-release compositions comprising a therapeutic agent for treating depression or anxiety and uses thereof | Jul 30, 2019 | Issued |
Array
(
[id] => 16581347
[patent_doc_number] => 20210015749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => NANOCOCHLEATE FORMULATION AND METHOD OF PREPARING THE NANOCOCHLEATE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 16/516493
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16516493
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/516493 | NANOCOCHLEATE FORMULATION AND METHOD OF PREPARING THE NANOCOCHLEATE FORMULATION | Jul 18, 2019 | Abandoned |
Array
(
[id] => 18201137
[patent_doc_number] => 11583508
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Use of mitoxantrone liposome for treating non-Hodgkin's lymphoma
[patent_app_type] => utility
[patent_app_number] => 17/258801
[patent_app_country] => US
[patent_app_date] => 2019-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8074
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17258801
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/258801 | Use of mitoxantrone liposome for treating non-Hodgkin's lymphoma | Jul 9, 2019 | Issued |
Array
(
[id] => 16837733
[patent_doc_number] => 20210145745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => TARGETED DELIVERY OF THERAPEUTIC AGENTS TO HUMAN ADIPOCYTES
[patent_app_type] => utility
[patent_app_number] => 17/250317
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17250317
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/250317 | Targeted delivery of therapeutic agents to human adipocytes | Jul 1, 2019 | Issued |
Array
(
[id] => 17109941
[patent_doc_number] => 20210290538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => MILK VESICLES FOR USE IN DELIVERING BIOLOGICAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/257452
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36406
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257452
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257452 | MILK VESICLES FOR USE IN DELIVERING BIOLOGICAL AGENTS | Jul 1, 2019 | Abandoned |
Array
(
[id] => 14990649
[patent_doc_number] => 20190314282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES
[patent_app_type] => utility
[patent_app_number] => 16/454555
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454555
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/454555 | Remote loading of sparingly water-soluble drugs into liposomes | Jun 26, 2019 | Issued |
Array
(
[id] => 17020793
[patent_doc_number] => 20210244664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => PHARMACEUTICAL COMPOSITIONS IN LYOPHILIZED FORM
[patent_app_type] => utility
[patent_app_number] => 17/251223
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251223
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251223 | PHARMACEUTICAL COMPOSITIONS IN LYOPHILIZED FORM | Jun 24, 2019 | Abandoned |
Array
(
[id] => 15020433
[patent_doc_number] => 20190321221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => INTRAOCULAR DELIVERY OF BIOACTIVE MOLECULES USING IONTOPHORESIS
[patent_app_type] => utility
[patent_app_number] => 16/448588
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16448588
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/448588 | INTRAOCULAR DELIVERY OF BIOACTIVE MOLECULES USING IONTOPHORESIS | Jun 20, 2019 | Abandoned |
Array
(
[id] => 15239723
[patent_doc_number] => 20190374647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => STABLE LIPOSOMES FOR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/440189
[patent_app_country] => US
[patent_app_date] => 2019-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16440189
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/440189 | STABLE LIPOSOMES FOR DRUG DELIVERY | Jun 12, 2019 | Abandoned |
Array
(
[id] => 19225239
[patent_doc_number] => 12004868
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Liposomal mitigation of drug-induced inhibition of the cardiac I
[patent_app_type] => utility
[patent_app_number] => 16/432498
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 33
[patent_no_of_words] => 21365
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16432498
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/432498 | Liposomal mitigation of drug-induced inhibition of the cardiac I | Jun 4, 2019 | Issued |
Array
(
[id] => 16990405
[patent_doc_number] => 20210228825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHODS FOR DIAGNOSING BRUGADA SYNDROME USING AN AEROSOL
[patent_app_type] => utility
[patent_app_number] => 16/972362
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -95
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972362
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/972362 | METHODS FOR DIAGNOSING BRUGADA SYNDROME USING AN AEROSOL | Jun 4, 2019 | Abandoned |
Array
(
[id] => 15020925
[patent_doc_number] => 20190321467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => LIPOSOME FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/426712
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16426712
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/426712 | Liposome formulations | May 29, 2019 | Issued |